OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4⁺T cells

10.1126/scitranslmed.3002842

10.1073/pnas.90.2.720

10.1158/0008-5472.CAN-07-1141

Hombach A, 2001, Cancer Res, 61, 1976

10.4049/jimmunol.172.1.104

10.4049/jimmunol.180.7.4901

10.1038/sj.leu.2403302

10.4049/jimmunol.173.10.5944

10.4049/jimmunol.175.10.6368

10.1038/nri1148

Calderhead DM, 1993, J Immunol, 151, 5261, 10.4049/jimmunol.151.10.5261

10.1615/CritRevImmunol.v29.i3.10

10.1016/S1074-7613(00)80143-0

Akiba H, 1999, J Immunol, 162, 7058, 10.4049/jimmunol.162.12.7058

10.1016/j.ymthe.2005.04.016

10.1007/s12026-011-8262-6

10.1046/j.1365-3083.2001.00851.x

10.4049/jimmunol.180.9.5771

10.1084/jem.174.4.915

10.4049/jimmunol.166.7.4312

10.1002/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.0.CO;2-E

10.1038/ni1504

10.1038/gt.2009.75

10.1002/ijc.25960

10.1158/1078-0432.CCR-08-3163

10.4049/jimmunol.165.6.3043

10.1038/nm.1882

10.1034/j.1600-065X.2003.00008.x

10.1038/mt.2011.9

10.2174/156652310791111001

Finney HM, 1998, J Immunol, 161, 2791, 10.4049/jimmunol.161.6.2791

10.4049/jimmunol.177.7.4288

10.1126/science.1088547

van Lunzen J, 2007, Mol Ther, 15, 1024, 10.1038/mt.sj.6300124

Newrzela S, 2011, Mol Med Published Online First, 27

10.1038/sj.gt.3300696

Kaulen H, 1993, Year Immunol, 7, 106

10.4049/jimmunol.167.11.6123